PRDA dividend yield – PT Prodia Widyahusada Tbk Declares 237.85392 Cash Dividend
May 29, 2023
Dividends Yield
On May 26, 2023, PT ($IDX:PRDA) Prodia Widyahusada Tbk declared a monumental 237.85392 cash dividend. This is a significant addition to their already impressive dividend yield over the past three years of 397.84, 397.84 and 172.0 IDR. This translates to a yield of 5.58%, 5.58% and 4.2% in 2021, 2022 and 2023 respectively, resulting in an average yield of 5.12%.
This dividend payout is an impressive reward for shareholders, delivering a healthy return on their investment. Therefore, this could be an attractive investment opportunity for those seeking to increase their portfolio returns.
Price History
This marked a 2.2% decrease from the previous closing price of 5675.0. PRODIA’s board of commissioners and directors are expecting the dividend declaration to further increase investor confidence and long term stock price performance of the company. Live Quote…
About the Company
Income Snapshot
Below shows the total revenue, net income and net margin for PRDA. More…
| Total Revenues | Net Income | Net Margin |
| 2.14M | 337.85k | 15.7% |
Cash Flow Snapshot
Below shows the cash from operations, investing and financing for PRDA. More…
| Operations | Investing | Financing |
| 550.22k | 239.96k | -439.05k |
Balance Sheet Snapshot
Below shows the total assets, liabilities and book value per share for PRDA. More…
| Total Assets | Total Liabilities | Book Value Per Share |
| 2.73M | 353.23k | 2.54k |
Key Ratios Snapshot
Some of the financial key ratios for PRDA are shown below. More…
| 3Y Rev Growth | 3Y Operating Profit Growth | Operating Margin |
| 7.3% | 25.6% | 20.1% |
| FCF Margin | ROE | ROA |
| 8.3% | 11.5% | 9.8% |
Analysis – PRDA Intrinsic Value Calculation
GoodWhale has conducted an analysis of the wellbeing of PT PRODIA WIDYAHUSADA TBK. Through our proprietary Valuation Line, we calculated the fair value of PT PRODIA WIDYAHUSADA TBK to be around IDR5242.8. However, currently the stock is being traded at a price of IDR5550.0 which is overvalued by 5.9%. This means that PT PRODIA WIDYAHUSADA TBK is overpriced at the current market rate and investors may want to reconsider their purchase decision. More…
Peers
PT Prodia Widyahusada Tbk is one of the leading health care companies in the industry, competing against other major players such as Avricore Health Inc, Sera Prognostics Inc, and Aspira Womens Health Inc. These companies are all striving to provide the best health care services to their customers, making it a highly competitive market. This competition drives innovation and greater efficiency, ultimately aiming to provide better health care solutions around the world.
– Avricore Health Inc ($TSXV:AVCR)
Avricore Health Inc is a Canadian public biotechnology company that specializes in preventive health products and services. The company’s market cap as of 2023 is 27.12M, making it one of the smaller companies in the industry. Avricore Health’s Return on Equity (ROE) is -27.1%, which is considered to be underperforming compared to the industry average and other competitors. The company’s mission is to improve the health of Canadians by providing evidence-based, preventive health solutions that are accessible, affordable, and easy to use. With its focus on preventive health solutions and services, Avricore Health Inc is poised to become an industry leader in the near future.
– Sera Prognostics Inc ($NASDAQ:SERA)
Sera Prognostics Inc is a healthcare company that develops medical technologies for early detection of severe preterm labor. With a market cap of 106.2M as of 2023, the company is well positioned to grow and expand its operations. Sera Prognostics’ return on equity (ROE) of -28.07% indicates that it may not be generating sufficient cash flow to cover its investment in operating assets. This could be an indicator that the company is either not using its assets efficiently or that the market has not fully valued the company’s potential. However, if the company can find ways to increase its ROE, there could be substantial upside for investors.
– Aspira Womens Health Inc ($NASDAQ:AWH)
Aspira Women’s Health Inc is a leading provider of reproductive health services for women in the United States. They offer a comprehensive range of services, including prenatal care, family planning, gynecology, infertility, and menopause care. As of 2023, their market cap stands at 29.15M, indicating a relatively small size in comparison to other players in the reproductive health industry. Additionally, their Return on Equity (ROE) is -484.32%, indicating that the company has been struggling to generate profits.
Summary
PT PRODIA WIDYAHUSADA TBK has offered investors a consistently attractive dividend yield over the last three years. The dividend per share has been 397.84, 397.84 and 172.0 IDR, resulting in a combined yield of 5.58%, 5.58% and 4.2%, respectively. The company may be a suitable investment option for those seeking long-term capital appreciation and dividend income.
